Pauwels Eric 4

Accession 0001323212-25-000003

CIK 0001070081other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:20 PM ET

Size

35.4 KB

Accession

0001323212-25-000003

Insider Transaction Report

Form 4

Period: 2025-12-17

PTC THERAPEUTICS, INC.PTCT

Pauwels Eric

CHIEF BUSINESS OFFICER

Transactions

Exercise/Conversion
Common Stock
2025-12-17$66.49/sh+1,245$82,780→ 74,157 total
Sale
Common Stock
2025-12-17$75.28/sh−1,245$93,724→ 72,912 total
Exercise/Conversion
Common Stock
2025-12-17$18.01/sh+3,684$66,349→ 74,157 total
Sale
Common Stock
2025-12-17$75.31/sh−3,584$269,911→ 70,473 total
Sale
Common Stock
2025-12-17$76.00/sh−100$7,600→ 70,373 total
Exercise/Conversion
Common Stock
2025-12-17$66.49/sh+35,361$2,351,153→ 105,734 total
Sale
Common Stock
2025-12-17$75.44/sh−35,261$2,660,090→ 70,473 total
Sale
Common Stock
2025-12-17$76.00/sh−100$7,600→ 70,373 total
Exercise/Conversion
Common Stock
2025-12-18$66.49/sh+120$7,979→ 70,493 total
Sale
Common Stock
2025-12-18$75.02/sh−120$9,002→ 70,373 total
Exercise/Conversion
Common Stock
2025-12-18$18.01/sh+251$4,521→ 70,624 total
Sale
Common Stock
2025-12-18$75.00/sh−251$18,825→ 70,373 total
Exercise/Conversion
Common Stock
2025-12-18$66.49/sh+2,831$188,233→ 73,204 total
Sale
Common Stock
2025-12-18$75.07/sh−2,831$212,523→ 70,373 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-17−36,606→ 22,894 total
Exercise: $66.49Exp: 2031-01-05→ Common Stock (36,606 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-17−3,684→ 18,382 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (3,684 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−2,951→ 19,943 total
Exercise: $66.49Exp: 2031-01-05→ Common Stock (2,951 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−251→ 18,131 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (251 underlying)

Footnotes (7)

[F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.
[F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F7]Currently exercisable.

Documents

1 file

4
form4-12192025_051201.xmlPrimary

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

→

Entity typeother

Related Parties

filerCIK 0001323212

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 5:20 PM ET
Size: 35.4 KB

View on SEC.gov